eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer Imaging
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
- Melodi Javid Whitley1,2,
- Diana M. Cardona3,
- Alexander L. Lazarides4,
- Ivan Spasojevic5,6,
- Jorge M. Ferrer7,
- Joan Cahill8,
- Chang-Lung Lee8,
- Matija Snuderl9,*,
- Dan G. Blazer III10,
- E. Shelley Hwang10,
- Rachel A. Greenup10,
- Paul J. Mosca10,
- Jeffrey K. Mito1,2,
- Kyle C. Cuneo8,
- Nicole A. Larrier8,
- Erin K. O’Reilly11,
- Richard F. Riedel5,
- William C. Eward12,
- David B. Strasfeld7,
- Dai Fukumura9,
- Rakesh K. Jain9,
- W. David Lee7,
- Linda G. Griffith13,
- Moungi G. Bawendi14,
- David G. Kirsch1,8,†,‡ and
- Brian E. Brigman12,‡
- 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
- 2Medical Science Training Program, Duke University Medical Center, Durham, NC 27710, USA.
- 3Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
- 4School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
- 5Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
- 6PK/PD Core Laboratory, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
- 7Lumicell Inc., Wellesley, MA 02481, USA.
- 8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
- 9Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
- 10Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
- 11Duke Translational Medicine Institute, Regulatory Affairs Group, Duke University Medical Center, NC 27710, USA.
- 12Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
- 13Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- 14Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- ↵†Corresponding author. E-mail: david.kirsch{at}duke.edu
See allHide authors and affiliations
Science Translational Medicine 06 Jan 2016:
Vol. 8, Issue 320, pp. 320ra4
DOI: 10.1126/scitranslmed.aad0293
Vol. 8, Issue 320, pp. 320ra4
DOI: 10.1126/scitranslmed.aad0293
Melodi Javid Whitley
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
2Medical Science Training Program, Duke University Medical Center, Durham, NC 27710, USA.
Diana M. Cardona
3Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Alexander L. Lazarides
4School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Ivan Spasojevic
5Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
6PK/PD Core Laboratory, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Jorge M. Ferrer
7Lumicell Inc., Wellesley, MA 02481, USA.
Joan Cahill
8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Chang-Lung Lee
8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Matija Snuderl
9Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Dan G. Blazer III
10Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
E. Shelley Hwang
10Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Rachel A. Greenup
10Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Paul J. Mosca
10Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Jeffrey K. Mito
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
2Medical Science Training Program, Duke University Medical Center, Durham, NC 27710, USA.
Kyle C. Cuneo
8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Nicole A. Larrier
8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Erin K. O’Reilly
11Duke Translational Medicine Institute, Regulatory Affairs Group, Duke University Medical Center, NC 27710, USA.
Richard F. Riedel
5Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
William C. Eward
12Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
David B. Strasfeld
7Lumicell Inc., Wellesley, MA 02481, USA.
Dai Fukumura
9Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Rakesh K. Jain
9Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
W. David Lee
7Lumicell Inc., Wellesley, MA 02481, USA.
Linda G. Griffith
13Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Moungi G. Bawendi
14Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
David G. Kirsch
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
8Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Brian E. Brigman
12Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Submit a Response to This Article
No eLetters have been published for this article.